1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab
- Contribution to journal › Article
- 2022
-
Mark
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease
- Contribution to journal › Article
- 2005
-
Mark
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
- Contribution to journal › Scientific review
